Trading · Founded 1993 · www.zenlabsethica.com · BSE 530697 · · ISIN INE546F01013
No Notes Added Yet
Business
Zenlabs Ethica Ltd. operates primarily in the Trading sector in India. As a trading company, its core business model involves procuring goods, products, or commodities from various sources and then selling them to customers or other businesses, typically at a higher price to generate a margin. The company makes money through the difference between its purchase price and selling price, factoring in operational costs such as logistics, storage, and administrative expenses. Its operations likely involve managing supply chains, inventory, and client relationships.
Revenue Mix
Without specific disclosures from the company, a typical trading company's revenue primarily stems from the buying and selling of its chosen range of goods or commodities. Revenue mix might be segmented by product category, geographical regions served, or type of clientele (e.g., B2B, B2C). For many trading firms, the primary source of revenue is the gross trading margin achieved on sales.
Industry
The trading industry in India is generally fragmented and highly competitive, characterized by numerous players ranging from small local traders to large diversified conglomerates. Zenlabs Ethica Ltd. operates within this environment, competing on factors such as pricing, supply chain efficiency, product availability, quality of service, and established relationships with suppliers and customers. Its specific positioning within this diverse landscape (e.g., niche product focus, geographic strength, scale of operations) would depend on its operational details.
MOAT
The trading business generally faces challenges in establishing strong, durable competitive advantages. Potential moats could arise from:
Proprietary Sourcing / Supplier Relationships: Exclusive or preferred agreements with key suppliers that offer cost advantages or unique products.
Strong Customer Relationships: Long-standing, trust-based relationships that ensure repeat business.
Logistical Efficiency: Superior supply chain management, warehousing, and distribution networks leading to lower costs or faster delivery.
Scale: Achieving economies of scale in procurement or logistics, though this is often difficult for smaller players.
However, these are often difficult to sustain against new entrants or aggressive competitors in a commoditized trading environment.
Growth Drivers
Key factors that can drive growth for Zenlabs Ethica Ltd. over the next 3-5 years include:
Expansion of Product Portfolio: Adding new products or categories to trade, catering to broader market demands.
Geographical Expansion: Entering new regional or international markets for sourcing or selling.
Increased Trade Volumes: Growing sales volumes through existing product lines and customer bases.
Optimized Supply Chain: Improving efficiency in sourcing and distribution to enhance margins.
Economic Growth: A generally robust economy in India can stimulate demand for various traded goods.
Risks
Commodity/Product Price Volatility: Fluctuations in purchase or selling prices can significantly impact trading margins.
Inventory Risk: Risk of obsolescence, damage, or decline in value of goods held in inventory.
Credit Risk: Potential for non-payment or delayed payment from customers.
Intense Competition: Pressure on margins due to a highly fragmented and competitive market.
Supply Chain Disruptions: Issues with sourcing, logistics, or transportation can impact operations and profitability.
Regulatory Changes: Changes in import/export policies, tariffs, or trade regulations could affect business.
Management & Ownership
Zenlabs Ethica Ltd., like many Indian companies, is likely promoter-driven, meaning a founding family or individual holds a significant stake and plays a key role in management. The quality and experience of the management team, particularly in sourcing, sales, and supply chain management, are crucial for navigating the competitive trading landscape. The ownership structure would typically involve the promoter group holding a majority or substantial stake, alongside public shareholders.
Outlook
Zenlabs Ethica operates in a fundamental yet challenging sector. The trading business offers potential for growth by leveraging strong relationships, efficient operations, and market understanding. However, it is inherently sensitive to market price fluctuations, intense competition, and broader economic conditions, which can lead to volatile profitability. The company's ability to identify profitable niches, maintain disciplined inventory management, and effectively manage its working capital will be critical for sustained performance and creating value. While a robust economy provides tailwinds, strong operational execution and risk management are paramount to navigate the thin margins and competitive pressures typical of the trading industry.
| #(Fig in Cr.) | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| Net Sales | 15 | 12 | 13 | 13 | 13 | 11 | 12 | 12 | 11 | 14 |
| Other Income | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total Income | 15 | 12 | 13 | 13 | 13 | 11 | 12 | 12 | 11 | 14 |
| Total Expenditure | 15 | 12 | 13 | 12 | 12 | 11 | 12 | 12 | 10 | 14 |
| Operating Profit | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 0 | -0 |
| Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Depreciation | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exceptional Income / Expenses | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -2 | 0 | 0 |
| Profit Before Tax | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -2 | 0 | -1 |
| Provision for Tax | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -0 | 0 | 0 |
| Profit After Tax | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -2 | 0 | -1 |
| Adjustments | 0 | 0 | 0 | 0 | 0 | -0 | 0 | -0 | -0 | 0 |
| Profit After Adjustments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -2 | 0 | -1 |
| Adjusted Earnings Per Share | 0.2 | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | -3.1 | 0 | -0.9 |
| #(Fig in Cr.) | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Sales | 0 | 16 | 81 | 72 | 67 | 60 | 57 | 69 | 67 | 59 | 51 | 49 |
| Other Income | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total Income | 0 | 16 | 81 | 72 | 67 | 60 | 57 | 69 | 67 | 59 | 51 | 49 |
| Total Expenditure | 0 | 16 | 80 | 70 | 65 | 61 | 55 | 67 | 64 | 56 | 49 | 48 |
| Operating Profit | -0 | 0 | 2 | 2 | 2 | -1 | 2 | 2 | 3 | 3 | 3 | 2 |
| Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 1 | 1 | 0 |
| Depreciation | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 1 | 1 | 1 | 1 | 0 |
| Exceptional Income / Expenses | 0 | -0 | 0 | 0 | 0 | 0 | 0 | 0 | -1 | 0 | 0 | -2 |
| Profit Before Tax | -0 | 0 | 1 | 2 | 2 | -1 | 1 | 1 | 1 | 1 | 0 | -3 |
| Provision for Tax | 0 | -0 | 0 | 0 | 1 | -0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Profit After Tax | -0 | 0 | 1 | 1 | 1 | -1 | 1 | 1 | 0 | 0 | 0 | -3 |
| Adjustments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Profit After Adjustments | -0 | 0 | 1 | 1 | 1 | -1 | 1 | 1 | 0 | 0 | 0 | -3 |
| Adjusted Earnings Per Share | -0.2 | 0.3 | 1.5 | 1.8 | 1.9 | -1.3 | 1.2 | 1.2 | 0.8 | 0.6 | 0.4 | -3.9 |
| # | 1 Year | 3 Year | 5 Year | 10 Year |
|---|---|---|---|---|
| Sales CAGR | -14% | -10% | -3% | 0% |
| Operating Profit CAGR | 0% | 14% | 0% | 0% |
| PAT CAGR | 0% | -100% | 0% | 0% |
| # | 1 Year | 3 Year | 5 Year | 10 Year |
|---|---|---|---|---|
| Share Price CAGR | -8% | -6% | -2% | 5% |
| ROE Average | 3% | 4% | 6% | 7% |
| ROCE Average | 6% | 8% | 11% | 10% |
| #(Fig in Cr.) | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Shareholder's Funds | 2 | 5 | 6 | 7 | 8 | 7 | 9 | 9 | 10 | 10 | 10 |
| Minority's Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Borrowings | 0 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 1 | 1 | 0 |
| Other Non-Current Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 2 | 3 | 3 | 2 | 1 |
| Total Current Liabilities | 2 | 25 | 27 | 22 | 26 | 26 | 21 | 25 | 29 | 27 | 28 |
| Total Liabilities | 4 | 30 | 33 | 30 | 35 | 34 | 32 | 38 | 43 | 40 | 40 |
| Fixed Assets | 0 | 2 | 2 | 1 | 1 | 1 | 4 | 4 | 5 | 4 | 2 |
| Other Non-Current Assets | 3 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 |
| Total Current Assets | 1 | 27 | 31 | 28 | 33 | 32 | 27 | 33 | 37 | 36 | 37 |
| Total Assets | 4 | 30 | 33 | 30 | 35 | 34 | 32 | 38 | 43 | 40 | 40 |
| #(Fig in Cr.) | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Opening Cash & Cash Equivalents | 0 | 0 | 2 | 1 | 1 | 2 | 10 | 2 | 2 | 2 | 1 |
| Cash Flow from Operating Activities | 0 | 1 | -1 | 0 | 1 | 0 | -8 | -0 | 2 | -9 | 4 |
| Cash Flow from Investing Activities | 0 | -2 | -0 | -0 | -0 | 0 | 0 | 0 | -1 | 0 | 0 |
| Cash Flow from Financing Activities | 0 | 3 | -0 | -0 | -0 | -0 | -1 | 0 | 0 | 8 | -3 |
| Net Cash Inflow / Outflow | 0 | 2 | -1 | 0 | 0 | 0 | -9 | -0 | 0 | -1 | 1 |
| Closing Cash & Cash Equivalent | 0 | 2 | 1 | 1 | 2 | 2 | 2 | 2 | 2 | 1 | 2 |
| # | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Earnings Per Share (Rs) | -0.17 | 0.26 | 1.46 | 1.79 | 1.94 | -1.33 | 1.18 | 1.2 | 0.75 | 0.65 | 0.41 |
| CEPS(Rs) | -0.15 | 0.35 | 1.78 | 2.1 | 2.29 | -0.88 | 2.28 | 2.57 | 2.67 | 2.64 | 2.35 |
| DPS(Rs) | 0 | 0 | 0.25 | 0 | 0 | 0 | 0 | 0 | 0.25 | 0 | 0 |
| Book NAV/Share(Rs) | 5.17 | 7.35 | 8.9 | 10.77 | 12.71 | 11.38 | 13.16 | 14.34 | 14.91 | 15.55 | 16.01 |
| Core EBITDA Margin(%) | 0 | 1.27 | 1.79 | 2.58 | 3.01 | -1.2 | 3.07 | 3.47 | 4.34 | 4.12 | 5 |
| EBIT Margin(%) | 0 | 0.72 | 1.64 | 2.43 | 2.92 | -1.56 | 2.03 | 2.3 | 1.81 | 2.42 | 2.63 |
| Pre Tax Margin(%) | 0 | 0.57 | 1.51 | 2.3 | 2.81 | -1.95 | 1.52 | 1.77 | 1.01 | 0.99 | 0.83 |
| PAT Margin (%) | 0 | 1.08 | 1.17 | 1.62 | 1.88 | -1.45 | 1.35 | 1.13 | 0.73 | 0.72 | 0.52 |
| Cash Profit Margin (%) | 0 | 1.45 | 1.42 | 1.9 | 2.21 | -0.96 | 2.62 | 2.42 | 2.6 | 2.93 | 2.98 |
| ROA(%) | -1.76 | 1 | 2.99 | 3.69 | 3.91 | -2.53 | 2.35 | 2.25 | 1.21 | 1.01 | 0.67 |
| ROE(%) | -3.31 | 5.04 | 17.99 | 18.18 | 16.53 | -11.05 | 9.61 | 8.74 | 5.14 | 4.25 | 2.62 |
| ROCE(%) | -3 | 2.9 | 21.03 | 23.85 | 23.44 | -11.27 | 13.77 | 16.21 | 10.34 | 7.91 | 5.96 |
| Receivable days | 0 | 196.28 | 89.23 | 120.44 | 133.29 | 143.7 | 132.5 | 104.67 | 115.8 | 132.2 | 142.89 |
| Inventory Days | 0 | 190.09 | 32.32 | 20.1 | 16.8 | 27.57 | 31.54 | 36.56 | 54.63 | 72.81 | 89.06 |
| Payable days | 0 | 359.88 | 129.18 | 141.08 | 149.78 | 167.43 | 162.61 | 132.91 | 161.78 | 156.54 | 129.56 |
| PER(x) | 0 | 54.63 | 23.49 | 27.7 | 29.7 | 0 | 17.94 | 23.72 | 91.88 | 64.14 | 75.48 |
| Price/Book(x) | 1.39 | 1.94 | 3.86 | 4.6 | 4.53 | 3.2 | 1.61 | 1.99 | 4.63 | 2.67 | 1.95 |
| Dividend Yield(%) | 0 | 0 | 0.69 | 0 | 0 | 0 | 0 | 0 | 0.36 | 0 | 0 |
| EV/Net Sales(x) | 0 | 0.5 | 0.27 | 0.44 | 0.54 | 0.37 | 0.22 | 0.27 | 0.69 | 0.67 | 0.59 |
| EV/Core EBITDA(x) | -53.13 | 17.52 | 14.47 | 16.36 | 16.66 | -34.06 | 6.68 | 7.41 | 15.26 | 14.42 | 11.62 |
| Net Sales Growth(%) | 0 | 0 | 415.23 | -11.48 | -6.32 | -10.92 | -5.52 | 21.98 | -3.19 | -12.44 | -12.19 |
| EBIT Growth(%) | -6.73 | 288.89 | 1068.58 | 31.24 | 12.51 | -147.69 | 222.65 | 38.66 | -24.13 | 17.17 | -4.37 |
| PAT Growth(%) | -17.67 | 356.39 | 459.01 | 22.29 | 8.56 | -168.58 | 188.57 | 1.92 | -37.44 | -13.92 | -36.09 |
| EPS Growth(%) | -17.63 | 249.6 | 459.01 | 22.29 | 8.56 | -168.58 | 188.56 | 1.92 | -37.44 | -13.92 | -36.09 |
| Debt/Equity(x) | 0 | 0.23 | 0.17 | 0.12 | 0.07 | 0.04 | 0.04 | 0.15 | 0.31 | 1.28 | 1.14 |
| Current Ratio(x) | 0.3 | 1.11 | 1.15 | 1.24 | 1.26 | 1.23 | 1.28 | 1.33 | 1.27 | 1.32 | 1.33 |
| Quick Ratio(x) | 0.3 | 0.78 | 0.92 | 1.17 | 1.09 | 1.05 | 1.04 | 0.98 | 0.89 | 0.87 | 0.86 |
| Interest Cover(x) | 0 | 4.81 | 13.12 | 19.22 | 27.01 | -4.03 | 3.99 | 4.29 | 2.26 | 1.7 | 1.46 |
| Total Debt/Mcap(x) | 0 | 0.12 | 0.04 | 0.03 | 0.02 | 0.01 | 0.03 | 0.07 | 0.07 | 0.48 | 0.58 |
| # | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| Promoter | 52.98 | 52.98 | 52.96 | 52.96 | 52.96 | 52.96 | 52.96 | 52.96 | 52.96 | 52.96 |
| FII | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| DII | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Public | 47.02 | 47.02 | 47.04 | 47.04 | 47.04 | 47.04 | 47.04 | 47.04 | 47.04 | 47.04 |
| Others | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 |
| # | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| Promoter | 0.34 | 0.34 | 0.34 | 0.34 | 0.34 | 0.34 | 0.34 | 0.34 | 0.34 | 0.34 |
| FII | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| DII | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Public | 0.31 | 0.31 | 0.31 | 0.31 | 0.31 | 0.31 | 0.31 | 0.31 | 0.31 | 0.31 |
| Others | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 0.65 | 0.65 | 0.65 | 0.65 | 0.65 | 0.65 | 0.65 | 0.65 | 0.65 | 0.65 |
| # | 1 Year | 3 Year | 5 Year | 10 Year |
|---|---|---|---|---|
| Sales CAGR | -14% | -10% | -3% | — |
| Operating Profit CAGR | 0% | +14% | — | — |
| PAT CAGR | — | -100% | — | — |
| Share Price CAGR | -8% | -6% | -2% | +5% |
| ROE Average | +3% | +4% | +6% | +7% |
| ROCE Average | +6% | +8% | +11% | +10% |
| # | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| Promoter | 52.98 | 52.98 | 52.96 | 52.96 | 52.96 | 52.96 | 52.96 | 52.96 | 52.96 | 52.96 |
| FII | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| DII | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Public | 47.02 | 47.02 | 47.04 | 47.04 | 47.04 | 47.04 | 47.04 | 47.04 | 47.04 | 47.04 |
| Others | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 |
| # | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| Promoter | 0.34 | 0.34 | 0.34 | 0.34 | 0.34 | 0.34 | 0.34 | 0.34 | 0.34 | 0.34 |
| FII | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| DII | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Public | 0.31 | 0.31 | 0.31 | 0.31 | 0.31 | 0.31 | 0.31 | 0.31 | 0.31 | 0.31 |
| Others | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 0.65 | 0.65 | 0.65 | 0.65 | 0.65 | 0.65 | 0.65 | 0.65 | 0.65 | 0.65 |
* The pros and cons are machine generated.
Our experts help you choose the right stocks based on performance, risk, and growth potential.
Looking to buy unlisted shares or need guidance on the investment process? Our expert Private Equity Advisors are here to assist you with accurate information, real-time pricing, and seamless execution.
Want to sell unlisted shares, liquidate your ESOPs, or understand the step-by-step process of liquidation? Connect with our Buying Team for smooth coordination, quick evaluations, and end-to-end support.
Planning to build or grow your portfolio? For Mutual Fund investments, PMS solutions, tailored portfolio creation, and overall wealth management, our dedicated Wealth Team is ready to guide you.
Your relationship manager will connect with you shortly.